Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
1974-6-10
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0040-5922
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
49
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
505-7
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:4595363-Clinical Trials as Topic,
pubmed-meshheading:4595363-Cyclopentanes,
pubmed-meshheading:4595363-Diabetic Retinopathy,
pubmed-meshheading:4595363-Fluorescein Angiography,
pubmed-meshheading:4595363-Humans,
pubmed-meshheading:4595363-Hypoglycemic Agents,
pubmed-meshheading:4595363-Platelet Adhesiveness,
pubmed-meshheading:4595363-Pyrroles,
pubmed-meshheading:4595363-Sulfonylurea Compounds
|
| pubmed:articleTitle |
[New aspects of the treatment of diabetic retinopathy].
|
| pubmed:publicationType |
Journal Article,
Clinical Trial
|